G. Vandermoten

1.0k total citations
21 papers, 753 citations indexed

About

G. Vandermoten is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, G. Vandermoten has authored 21 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in G. Vandermoten's work include Lung Cancer Research Studies (14 papers), Neuroendocrine Tumor Research Advances (9 papers) and Cancer therapeutics and mechanisms (6 papers). G. Vandermoten is often cited by papers focused on Lung Cancer Research Studies (14 papers), Neuroendocrine Tumor Research Advances (9 papers) and Cancer therapeutics and mechanisms (6 papers). G. Vandermoten collaborates with scholars based in Belgium and United States. G. Vandermoten's co-authors include Jean‐Paul Sculier, P Libert, Jean Klášterský, P Ravez, G. Bureau, G Dabouis, J Thiriaux, J. Michel, Michel Richez and H. Lacroix and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

G. Vandermoten

19 papers receiving 703 citations

Peers

Countries citing papers authored by G. Vandermoten

Since Specialization

Citations

This map shows the geographic impact of G. Vandermoten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Vandermoten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Vandermoten more than expected).

Fields of papers citing papers by G. Vandermoten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Vandermoten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Vandermoten. The network helps show where G. Vandermoten may publish in the future.

Co-authorship network of co-authors of G. Vandermoten

This figure shows the co-authorship network connecting the top 25 collaborators of G. Vandermoten. A scholar is included among the top collaborators of G. Vandermoten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Vandermoten. G. Vandermoten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiation Therapy for Nonsmall-Cell Lung Cancer 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·P. Van Houtte, Jean Klášterský, A. Renaud, J. Michel, G. Vandermoten, (unknown), J.P. Sculier, Jacques Devriendt, P. Mommen	0
2	New concept using Passive Infrared (PIR) technology for a contactless detection of breathing movement: a pilot study involving a cohort of 169 adult patients 2013 ·Journal of Clinical Monitoring and Computing ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), G. Vandermoten, (unknown)	19
3	Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party. 1993 ·Journal of Clinical Oncology ·Jean‐Paul Sculier, Marianne Paesmans, G. Bureau, G Dabouis, P Libert, G. Vandermoten, O Van Cutsem, M.C. Berchier, F. Ries, J. Michel	61
4	A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: A preliminary report 1990 ·Seminars in Oncology ·Jean Klášterský, (unknown), G Dabouis, G. Bureau, P Libert, (unknown), G. Vandermoten, J Thiriaux, (unknown), (unknown), (unknown), Marianne Paesmans, (unknown)	25
5	A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. 1990 ·Journal of Clinical Oncology ·Jean Klášterský, Jean‐Paul Sculier, H. Lacroix, G Dabouis, G. Bureau, P Libert, Michel Richez, P Ravez, G. Vandermoten, J Thiriaux	198
6	A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer 1990 ·Annals of Oncology ·Jean‐Paul Sculier, Jean Klášterský, P Libert, P Ravez, J Thiriaux, J. Lecomte, G. Bureau, G. Vandermoten, G Dabouis, J. Michel, J Schmerber, R Sergysels, D. Becquart, P. Mommen, M. Paesmans	18
7	A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party. 1990 ·PubMed ·Jean Klášterský, (unknown), G Dabouis, G. Bureau, P Libert, P Ravez, G. Vandermoten, J Thiriaux, J. Lecomte, (unknown)	3
8	Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium. 1989 ·Journal of Clinical Oncology ·Jean Klášterský, Jean‐Paul Sculier, G. Bureau, P Libert, P Ravez, G. Vandermoten, J Thiriaux, J. Lecomte, (unknown), G Dabouis	113
9	Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer 1988 ·European Journal of Cancer and Clinical Oncology ·Jean‐Paul Sculier, Jean Klášterský, D. Becquart, G. Vandermoten, P. Van Houtte, P Rocmans, J Thiriaux, E Longeval, P Ravez, P Libert, (unknown), (unknown), M Mairesse, P. Mommen, Otilia Dalesio	10
10	Oral etoposide preceding cisplatin in advanced non small cell lung cancer (NSCLC). A phase II study 1988 ·European Journal of Cancer and Clinical Oncology ·C Focan, G. Vandermoten, (unknown), Denis Schallier	1
11	Bronchial obstruction caused by a solitary endobronchial non-Hodgkin lymphoma. 1987 ·PubMed ·Herbert Spapen, (unknown), E. Eeckhout, G. Vandermoten, (unknown)	3
12	Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: A pilot study by the lung cancer working party (Belgium) 1987 ·Lung Cancer ·Jean‐Paul Sculier, Jean Klášterský, (unknown), G. Vandermoten, P Rocmans, P Libert, P Ravez, D. Becquart, P. Mommen, Otilia Dalesio	12
13	Increased plasma motilin concentrations in small cell carcinoma of the lung. 1987 ·Thorax ·A Noseda, T. L. Peeters, Myriam Delhaye, V. Bormans, (unknown), G. Vandermoten, (unknown), P Rocmans, J C Yernault	13
14	Immunologic Properties of Methionine‐Enkephalin, and Therapeutic Implications in AIDS, ARC, and Cancer 1987 ·Annals of the New York Academy of Sciences ·Joseph Wybran, Liliane Schandené, (unknown), G. Vandermoten, Dominique Latinne, J. Sonnet, (unknown), H. Taelman, Nicholas P. Plotnikoff	43
15	A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma. 1986 ·Journal of Clinical Oncology ·Jean Klášterský, Jean‐Paul Sculier, P Ravez, P Libert, J. Michel, G. Vandermoten, P Rocmans, (unknown), M Mairesse, (unknown)	117
16	[Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results]. 1986 ·PubMed ·(unknown), Jean Klášterský, Nicholas D. Nguyen, D. Becquart, G. Vandermoten, P Rocmans, J. Michel, L Debusscher, E Longeval, M Mairesse	1
17	Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium) 1985 ·Cancer ·(unknown), Jean‐Paul Sculier, (unknown), D. Becquart, G. Vandermoten, P Rocmans, J. Michel, E Longeval, Otilia Dalesio	16
18	Partial bronchial stenosis following inadvertent right bronchial intubation in a neonate. 1985 ·PubMed ·(unknown), Anne Pardou, (unknown), Danièle Vermeylen, (unknown), G. Vandermoten, (unknown)	6
19	Asbestos bodies in bronchoalveolar lavage. 1982 ·PubMed ·Paul De Vuyst, Jacques Jedwab, Pascal Dumortier, G. Vandermoten, (unknown), Jean Claude Yernault	49
20	Tc-99m-diethyl-IDA imaging: clinical evaluation in jaundiced patients. 1980 ·PubMed ·Stanislas Pauwels, (unknown), André Schoutens, G. Vandermoten, Christian Beckers	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact